Frontlight ResearchEarly access
Trial site
Life Care Hospital and Research Centre
- 9running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes11 trials
- Obesity10 trials
- Chronic kidney disease4 trials
- High blood pressure3 trials
- Heart failure2 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Obstructive sleep apnoea1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 313 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Suspended2 trials
- Lead sponsor
- Eli Lilly and Company11 trials
- Novo Nordisk A/S4 trials
- Sun Pharmaceutical Industries Limited1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Chronic kidney disease2 recruiting
- Obesity2 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026